secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001104659-26-006236
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics regains Nasdaq bid price compliance; reverse split not needed
--------------------------------------------------------------------------------

- Nasdaq notified Century on Jan 22, 2026 that it regained compliance with minimum $1.00 bid price rule.
- Stockholders approved reverse stock split (1:5–1:30) at special meeting earlier that day.
- Company will not implement the reverse split due to regained compliance.
- No other business was conducted; adjournment proposal was unnecessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926006236/0001104659-26-006236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926006236/tm263921d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-006236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer